enVVeno Medical (NVNO) Income Statement: Revenue & Earnings

enVVeno Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

enVVeno Medical Corporation income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.53	0.00	0.00	0.00	0.00
Gross Profit	-0.53	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	12.25	13.58	9.91	5.73	4.25
Selling, General & Administrative	11.58	11.66	15.02	11.17	4.88
Operating Expenses	23.83	25.24	24.93	16.89	9.14
Operating Income	-23.83	-25.24	-24.93	-16.89	-9.14
Other Income/Expense
Interest Income	0.39	0.18	0.16	0.02	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	2.01	-1.54	0.10	0.03	0.00
Income
Income Before Tax	-21.82	-23.52	-24.67	-16.53	-9.14
Income Tax Expense	0.00	-4.17	-3.77	-2.70	0.00
Net Income	-21.82	-23.52	-24.67	-16.53	-9.14
Net Income - Continuous Operations	-21.82	-23.52	-24.67	-16.53	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-23.64	-27.14	-24.41	-16.74	-9.04
EBIT	-23.83	-27.68	-24.93	-16.89	-9.14
Depreciation & Amortization	0.19	0.20	0.20	0.15	0.10
Earnings Per Share
Basic EPS	-45.00	-2.00	-2.00	-67.00	-264.00
Diluted EPS	-45.00	-2.00	-2.00	-67.00	-264.00
Basic Shares Outstanding	0.49	12.30	11.23	0.25	0.04
Diluted Shares Outstanding	0.49	12.30	11.23	0.25	0.04